MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Holmes tremor (HT) associated with brainstem cavernous venous malformation (cavernoma) and acute hydrocephalus

    I. Sudath, I. Rajapakshe, B. Senanayake (colombo 07, Sri Lanka)

    Objective: To report a case of brainstem cavernoma associated HT and literature review. Background: Holmes tremor is described by James Holmes in1904.Used to known as…
  • MDS Virtual Congress 2020

    Benefits of Recreational Therapy and Speech Therapy among Participants with Parkinson’s Disease: Findings from a 12-month study

    S. Parveen, B. Brickell, C. Romoser, H. Wilson, T. Passmore, M. Bateman (Stillwater, OK, USA)

    Objective: The current study reports findings from a year-long community-based multidisciplinary program for individuals with Parkinson's disease (PD). Background: Parkinson's disease is a multimodality disorder…
  • MDS Virtual Congress 2020

    Association of TTPA mutation and peripheral nerve involvement in Gait disturbances in Ataxia With Vitamin E Deficiency (AVED)

    D. dos Santos, C. de Oliveira, F. Kok (Sao Paulo, Brazil)

    Objective: To determine if peripheral nerve involvement and the type of TTPA mutation are determinant for gait ataxia in patients with AVED in vitamin E…
  • MDS Virtual Congress 2020

    Genetic, biochemical and clinical findingss in Friedreich’s ataxia patients – relationship with the disease severity

    R. Moganty, D. Pathak, A. srivastava, s. Gulati (New Delhi, India)

    Objective: To investigate the correlation of disease severity in terms of clinical, genetic and molecular parameters in FRDA. Background: : Friedreich ataxia (FRDA) is a…
  • MDS Virtual Congress 2020

    The use of Virtual Reality to Assess the Quality of Life in Patients with Spinocerebellar Ataxia

    B. Zeigelboim, B. Cavalcante-Leao, J.M Malisky, G.S Santos, M.S Severiani, H.T Teive (Curitiba, Brazil)

    Objective: To assess independence, confidence and balance for  development daily activities in patients with SCAs, before and after rehabilitation with virtual reality (ViR). Background: Spinocerebellar…
  • MDS Virtual Congress 2020

    Deutetrabenazine Reduces Involuntary Movements in Patients Most Severely Impacted by Tardive Dyskinesia in a 3-year Open-Label Extension Trial

    J. Bona, H. Barkay, A. Wilhelm, N. Chaijale, M. Gordon (Atlanta, GA, USA)

    Objective: To evaluate the efficacy of deutetrabenazine (DTBZ) in reducing TD in the most severely impacted patients using data from an ongoing open-label extension (OLE)…
  • MDS Virtual Congress 2020

    Substantia nigra echogenicity as a predictor of drug withdrawal response in suspected drug-induced parkinsonism: a five year follow-up study

    B. Baena Álvarez, R. Sainz Amo, F. Rodríguez Jorge, J. Gómez Corral, F.J Buisán Catevilla, N. García Barragán, I. Corral Corral, A. Felipe Mimbrera, M.C Matute Lozano, J. Masjuán Vallejo, J.C Martínez Castillo, J.L López-Sendón, A. Alonso Cánovas (Madrid, Spain)

    Objective: To asses the role of transcranial sonography in suspected drug-induced parkinsonism. Background: Differential diagnosis between drug-induced parkinsonism (DIP) and Parkinson’s disease (PD) is challenging,…
  • MDS Virtual Congress 2020

    Patient experiences of cervical dystonia management with botulinum toxin A: A comparison of US versus European survey findings

    C. Comella, J. Ferreira, M. Azoulai, E. Pain, S. Om (Chicago, IL, USA)

    Objective: Evaluate differences in the botulinum neurotoxin type A (BoNT-A) treatment experience between patients with cervical dystonia (CD) treated in the United States (US) versus…
  • MDS Virtual Congress 2020

    Mutation screening and clinical features analysis in patients with early-onset primary dystonia

    X.J Gu, J. Yang, L.Y Zhang, QQ. Wei, H.F Shang (Chengdu, China)

    Objective: In this context, it is important to reveal the mutation frequency of primary dystonia related genes using target dystonia related gene panel among a…
  • MDS Virtual Congress 2020

    Late-Onset Dopa-Responsive Dystonia: A Case Report

    O. Oztop Cakmak, S. Ertan, S. Tekgul, N. Basak (Istanbul, Turkey)

    Objective: To present a rare cause of treatable dystonia with onset during adulthood. Background: L-Dopa-responsive dystonia is an inherited disorder characterized by early-onset dystonia affecting…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley